Literature DB >> 2785451

Same day injections of Tc-99m methoxy isobutyl isonitrile (hexamibi) for myocardial tomographic imaging: comparison between rest-stress and stress-rest injection sequences.

R Taillefer1, A Gagnon, L Laflamme, J Grégoire, J Léveillé, D C Phaneuf.   

Abstract

It has been shown that both rest and stress 99mTc-hexamibi myocardial perfusion imaging can be performed on the same day using two different doses injected within few hours (the first one at rest followed by a second at stress). In order to evaluate and compare 2 sequences (rest-stress and stress-rest) of 99mTc-hexamibi injections performed the same day, 18 patients with either abnormal 201Tl myocardial scan or abnormal coronary angiography were studied with 2 99mTc-hexamibi injections protocols. The rest-stress study was performed as follows: 7 mCi 99mTc-hexamibi was injected at rest. Single photon emission computed tomography (SPECT) was performed 60 min later. Immediately after the rest study, patients were injected at peak stress with 25 mCi 99mTc-hexamibi. Tomographic imaging was repeated 1 h later. Patients were submitted to the stress-rest protocol within 3 days. Tomographic imaging was done 1 h after a 7 mCi injection at stress. This study was followed by an injection of 25 mCi 99mTc-hexamibi at rest, a tomographic study was performed 60 min later. Myocardial sections were reconstructed in horizontal long, vertical long, and short axes. Data analysis also included polar map representation. A total of 324 segments were interpreted blind by 3 observers, there was an agreement in 283/324 (87.3%) segments between the 2 protocols. However, 24 segments (7.4%) judged ischemic on rest-stress were called scars on stress-rest.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2785451     DOI: 10.1007/bf00254621

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  11 in total

1.  The utilization of Tc-99m-TBI as a myocardial perfusion agent in exercise studies: comparison with Tl-201 thallous chloride and examination of its biodistribution in humans.

Authors:  S T Sia; B L Holman; K McKusick; P Rigo; F Gillis; V Sporn; N Perez-Balino; A Mitta; H Vosberg; Z Szabo
Journal:  Eur J Nucl Med       Date:  1986

2.  Hexakis(carbomethoxyisopropylisonitrile) technetium(I), a new myocardial perfusion imaging agent: binding characteristics in cultured chick heart cells.

Authors:  D Piwnica-Worms; J F Kronauge; B L Holman; J Lister-James; A Davison; A G Jones
Journal:  J Nucl Med       Date:  1988-01       Impact factor: 10.057

3.  Hexakis (2-methoxy isobutylisonitrile) technetium-99m and thallium-201 chloride: uptake and release in cultured myocardial cells.

Authors:  J C Maublant; P Gachon; N Moins
Journal:  J Nucl Med       Date:  1988-01       Impact factor: 10.057

4.  Myocardial perfusion imaging with a new radiotracer, technetium-99m-hexamibi (methoxy isobutyl isonitrile): comparison with thallium-201 imaging.

Authors:  R Taillefer; G Dupras; V Sporn; P Rigo; J Leveille; P Boucher; N Perez-Balino; L L Camin; K A McKusick
Journal:  Clin Nucl Med       Date:  1989-02       Impact factor: 7.794

5.  Myocardial imaging with technetium-99m CPI: initial experience in the human.

Authors:  B L Holman; V Sporn; A G Jones; S T Sia; N Perez-Balino; A Davison; J Lister-James; J F Kronauge; A E Mitta; L L Camin
Journal:  J Nucl Med       Date:  1987-01       Impact factor: 10.057

6.  Myocardial perfusion imaging with 99mTc-methoxy-isobutyl-isonitrile (MIBI): comparison of short and long time intervals between rest and stress injections. Preliminary results.

Authors:  R Taillefer; L Laflamme; G Dupras; M Picard; D C Phaneuf; J Léveillé
Journal:  Eur J Nucl Med       Date:  1988

7.  The scintigraphic evaluation of myocardial infarction and regional ventricular performance using technetium-99m hexakis (t-butylisonitrile) technetium (I) (TBI): a new myocardial imaging agent.

Authors:  S Campbell; B L Holman; J M Kirshenbaum; E M Antman; J Lister-James; A Davison; J Kozlowski; R J English; A G Jones
Journal:  Eur J Nucl Med       Date:  1986

8.  The utilization of technetium-99m CPI as a myocardial perfusion imaging agent in exercise studies.

Authors:  S T Sia; B L Holman; S Campbell; J Lister-James; R J English; J F Kronauge; A Davison; A G Jones
Journal:  Clin Nucl Med       Date:  1987-09       Impact factor: 7.794

9.  Biological studies of a new class of technetium complexes: the hexakis(alkylisonitrile)technetium(I) cations.

Authors:  A G Jones; M J Abrams; A Davison; J W Brodack; A K Toothaker; S J Adelstein; A I Kassis
Journal:  Int J Nucl Med Biol       Date:  1984

10.  Uptake of hexakis(t-butylisonitrile) technetium (I) and hexakis(isopropylisonitrile) technetium (I) by neonatal rat myocytes and human erythrocytes.

Authors:  H Sands; M L Delano; B M Gallagher
Journal:  J Nucl Med       Date:  1986-03       Impact factor: 10.057

View more
  27 in total

1.  Gating of myocardial perfusion imaging for the identification of artifacts: is it useful for experienced physicians?

Authors:  S N Chatziioannou; W H Moore; R D Dhekne; P V Ford
Journal:  Tex Heart Inst J       Date:  2000

Review 2.  An overview of contemporary nuclear cardiology.

Authors:  Howard C Lewin; Maria G Sciammarella; Thomas A Watters; Herbert G Alexander
Journal:  Curr Cardiol Rep       Date:  2004-01       Impact factor: 2.931

3.  The clinical importance of accurate measurement of injected doses for radionuclide myocardial perfusion imaging.

Authors:  Raymond Taillefer
Journal:  J Nucl Cardiol       Date:  2015-08-26       Impact factor: 5.952

4.  Quantitative SPECT by attenuation correction of the projection set using transmission data: evaluation of a method.

Authors:  H Almquist; J Palmer; M Ljungberg; P Wollmer; S E Strand; B Jonson
Journal:  Eur J Nucl Med       Date:  1990

5.  Role of the technologist in nuclear cardiology.

Authors:  A Mann; M P White
Journal:  J Nucl Cardiol       Date:  1998 Jul-Aug       Impact factor: 5.952

Review 6.  What is the current status of quantification and nuclear medicine in cardiology?

Authors:  G Hör
Journal:  Eur J Nucl Med       Date:  1996-07

Review 7.  Choosing a thallium-201 or technetium 99m sestamibi imaging protocol.

Authors:  J E Udelson
Journal:  J Nucl Cardiol       Date:  1994 Sep-Oct       Impact factor: 5.952

Review 8.  The maze of myocardial perfusion imaging protocols in 1994.

Authors:  F J Wackers
Journal:  J Nucl Cardiol       Date:  1994 Mar-Apr       Impact factor: 5.952

9.  Preliminary evaluation in humans of Tc-99m-Q3, a new tracer for myocardial perfusion imaging.

Authors:  G Bisi; R Sciagrà; L Bacciottini; D Antoniucci; G M Santoro; P Buonamici; C Bonino
Journal:  Int J Card Imaging       Date:  1993-03

10.  Technetium-99m teboroxime scintigraphy. Clinical experience in patients referred for myocardial perfusion evaluation.

Authors:  L Bontemps; X Geronicola-Trapali; Y Sayegh; O Delmas; R Itti; X André-Fouët
Journal:  Eur J Nucl Med       Date:  1991
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.